MCL patient characteristics (n = 13)
| Patient characteristics . | MCL disease features . | MCL transplantation features . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPN . | Age, y . | Sex . | BM involved . | Ki67 index . | No. of prior regimens . | Mo from prior R . | PET status at HCT . | MCL status at HCT . | Time from diagnosis to HCT, mo . | Donor sex/age, y . | RD/URD . |
| 3411 | 55 | M | Y | 30% | 2 | 2 | + | PR | 16 | M/35 | URD |
| 3439 | 64 | M | N | 80% | 5 | 2 | No PET | PR | 36 | F/55 | RD |
| 3489 | 57 | F | Y | NA | 3 | 2 | + | PR | 44 | M/55 | RD |
| 3547 | 63 | M | Y | NA | 4 | 3 | − | PR | 72 | F/65 | RD |
| 3567 | 55 | F | Y | 40% | 1 | 2 | − | CR | 6 | M/48 | RD |
| 3580 | 63 | M | Y | NA | 2 | 2 | − | CR | 18 | M/47 | RD |
| 3635 | 63 | M | Y | 75% | 1 | 2 | − | CR | 6 | M/37 | URD |
| 3636 | 50 | F | Y | NA | 1 | 4 | − | CR | 7 | F/53 | RD |
| 3807 | 62 | M | Y | NA | 1 | 3 | − | CR | 8 | M/27 | URD-A allele MM |
| 3814 | 60 | F | N | 30% | 2 | 1 | − | CR | 38 | F/25 | URD |
| 3842 | 58 | M | Y | > 90% | 3 | 1 | − | CR | 28 | F/26 | URD |
| 3928 | 66 | F | Y | 90% | 1 | 3 | − | CR | 7 | M/21 | URD |
| 3969 | 56 | M | Y | 50% | 1 | 1 | − | CR | 6 | M/53 | RD |
| Patient characteristics . | MCL disease features . | MCL transplantation features . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPN . | Age, y . | Sex . | BM involved . | Ki67 index . | No. of prior regimens . | Mo from prior R . | PET status at HCT . | MCL status at HCT . | Time from diagnosis to HCT, mo . | Donor sex/age, y . | RD/URD . |
| 3411 | 55 | M | Y | 30% | 2 | 2 | + | PR | 16 | M/35 | URD |
| 3439 | 64 | M | N | 80% | 5 | 2 | No PET | PR | 36 | F/55 | RD |
| 3489 | 57 | F | Y | NA | 3 | 2 | + | PR | 44 | M/55 | RD |
| 3547 | 63 | M | Y | NA | 4 | 3 | − | PR | 72 | F/65 | RD |
| 3567 | 55 | F | Y | 40% | 1 | 2 | − | CR | 6 | M/48 | RD |
| 3580 | 63 | M | Y | NA | 2 | 2 | − | CR | 18 | M/47 | RD |
| 3635 | 63 | M | Y | 75% | 1 | 2 | − | CR | 6 | M/37 | URD |
| 3636 | 50 | F | Y | NA | 1 | 4 | − | CR | 7 | F/53 | RD |
| 3807 | 62 | M | Y | NA | 1 | 3 | − | CR | 8 | M/27 | URD-A allele MM |
| 3814 | 60 | F | N | 30% | 2 | 1 | − | CR | 38 | F/25 | URD |
| 3842 | 58 | M | Y | > 90% | 3 | 1 | − | CR | 28 | F/26 | URD |
| 3928 | 66 | F | Y | 90% | 1 | 3 | − | CR | 7 | M/21 | URD |
| 3969 | 56 | M | Y | 50% | 1 | 1 | − | CR | 6 | M/53 | RD |
R indicates rituximab; RD, matched related donor; URD, unrelated donor; MM, mismatch; NA, not available; and PET, positron emission tomography.